Chinese Journal of Tuberculosis and Respiratory Diseases recommended the use of Pirfenidone as an anti-fibrosis therapy for COVID-19 patients in China へのコメント

Chinese Journal of Tuberculosis and Respiratory Diseases recommended the use of Pirfenidone as an anti-fibrosis therapy for COVID-19 patients in China へのコメント /english/information/news/1645/ 株式会社ジーエヌアイグループ公式Webサイト Mon, 20 Feb 2023 13:39:36 +0000 hourly 1 https://wordpress.org/?v=6.5.5